Banco Santander S.A. Makes New $647,000 Investment in Doximity, Inc. (NASDAQ:DOCS)

Banco Santander S.A. purchased a new position in Doximity, Inc. (NASDAQ:DOCS - Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 14,855 shares of the company's stock, valued at approximately $647,000.

Several other hedge funds also recently bought and sold shares of DOCS. First Horizon Advisors Inc. grew its holdings in shares of Doximity by 22.5% during the third quarter. First Horizon Advisors Inc. now owns 2,094 shares of the company's stock worth $91,000 after purchasing an additional 384 shares in the last quarter. GAMMA Investing LLC grew its stake in Doximity by 40.1% in the 3rd quarter. GAMMA Investing LLC now owns 1,439 shares of the company's stock worth $63,000 after buying an additional 412 shares in the last quarter. Van ECK Associates Corp increased its holdings in shares of Doximity by 19.7% in the 2nd quarter. Van ECK Associates Corp now owns 2,590 shares of the company's stock worth $72,000 after buying an additional 427 shares during the last quarter. Cornercap Investment Counsel Inc. raised its position in shares of Doximity by 3.2% during the 2nd quarter. Cornercap Investment Counsel Inc. now owns 17,143 shares of the company's stock valued at $479,000 after buying an additional 537 shares in the last quarter. Finally, Farther Finance Advisors LLC lifted its holdings in shares of Doximity by 324.2% during the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company's stock worth $34,000 after acquiring an additional 603 shares during the last quarter. Hedge funds and other institutional investors own 87.19% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts have weighed in on DOCS shares. Bank of America raised their price target on Doximity from $32.00 to $45.00 and gave the company a "neutral" rating in a research report on Monday, October 7th. Morgan Stanley upgraded Doximity from an "underweight" rating to an "equal weight" rating and boosted their target price for the stock from $33.00 to $53.00 in a research report on Thursday, November 14th. The Goldman Sachs Group initiated coverage on shares of Doximity in a research report on Friday, November 15th. They set a "neutral" rating and a $58.00 price target on the stock. JPMorgan Chase & Co. boosted their price objective on shares of Doximity from $30.00 to $48.00 and gave the stock a "neutral" rating in a report on Thursday. Finally, Canaccord Genuity Group lowered shares of Doximity from a "buy" rating to a "hold" rating and increased their target price for the company from $40.00 to $60.00 in a report on Wednesday, November 13th. Eleven analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, Doximity currently has an average rating of "Hold" and an average target price of $52.27.

Doximity Price Performance

Doximity stock traded up $0.20 during mid-day trading on Friday, reaching $48.20. 2,135,681 shares of the company traded hands, compared to its average volume of 2,385,507. The firm's 50 day moving average price is $44.64 and its 200 day moving average price is $35.08. Doximity, Inc. has a 52-week low of $22.96 and a 52-week high of $61.75. The firm has a market capitalization of $9.00 billion, a price-to-earnings ratio of 55.40, a P/E/G ratio of 3.89 and a beta of 1.30.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.